Centro de Documentacion de Fundación MAPFRE - What to do at low doses : a bounding approach for economic analysis

Notas: The article examines the implications for benefit-cost analysis of carcinogenic exposures of the proposed changes to the 1986 Guideliness and proposes an approach for building dose-response relationships when no biologically based models are available. This approach yields estimates of reduced illness for use in a benefit-cost analysis while incorporating evidence of nonlinearities in the dose-response relationshipRegistros relacionados: En: Risk analysis : an international journal. - New York and London : Society for Risk Analysis. - Vol. 22, nº 4, August, 2002 ; p. 679-688Materia / lugar / evento: Cáncer Seguro de enfermedades graves Relación costo-beneficio Evaluación de riesgos Análisis de riesgos Valoración de riesgos Salud Gerencia de riesgos Otros autores: Griffiths, Charles W.
Otras clasificaciones: 7